Recombination in Hepatitis C Virus During Treatment
Author Information
Author(s): María P. Moreno, Didier Casane, Lilia López, Juan Cristina
Primary Institution: Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay
Hypothesis
The study investigates the role of recombination in the evolution of Hepatitis C virus quasispecies during anti-viral therapy.
Conclusion
Only one recombinant strain was detected in all patient quasispecies populations studied, suggesting that recombination may not be extensive in NS5A genes of HCV during antiviral therapy.
Supporting Evidence
- A crossing-over event in the NS5A gene was identified after four weeks of treatment.
- Putative parental-like strains were identified from previous weeks in the same patient.
- Only one recombinant strain was observed among all studied populations.
Takeaway
The researchers looked at how the Hepatitis C virus changes when patients are treated, and they found only one case of the virus mixing its genes.
Methodology
Phylogenetic analysis of HCV quasispecies populations was performed using SimPlot and bootscanning methods.
Limitations
The true frequency of recombination may be underestimated due to the need for significant differences among strains for detection.
Participant Demographics
All patients had genotype 1b infection.
Statistical Information
P-Value
<0.004
Statistical Significance
p<0.004
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website